FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Anuh Pharma's Free Cash Flow for the
three
months ended in Mar. 2026 was ₹0 Mil. Anuh Pharma's Revenue for the
three
months ended in Mar. 2026 was ₹2,021 Mil. Therefore, Anuh Pharma's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Anuh Pharma's FCF Margin % or its related term are showing as below:
BOM:506260'
s FCF Margin % Range Over the Past 10 Years
Min: -6.8 Med: 1.9 Max: 12.09
Current: -1.41
During the past 13 years, the highest FCF Margin % of Anuh Pharma was 12.09%. The lowest was -6.80%. And the median was 1.90%.
BOM:506260's FCF Margin % is ranked worse than 60.83% of 960
companies
in the Drug Manufacturers industry
Industry Median: 2.48
vs BOM:506260: -1.41
Anuh Pharma FCF Margin % Related Terms
Anuh Pharma FCF Margin % Historical Data
* Premium members only.
The historical data trend for Anuh Pharma's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Anuh Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anuh Pharma FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Anuh Pharma's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Anuh Pharma's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anuh Pharma (BOM:506260) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Anuh Pharma and its competitors. According to the industry distribution chart, Anuh Pharma ranks #584 out of 960 companies in the Drug Manufacturers industry, placing it in the top 60.8%.
Is Anuh Pharma's FCF Margin % too high?
Anuh Pharma's current FCF Margin % is 0.00%. Based on the distribution chart, Anuh Pharma ranks #584 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Anuh Pharma has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Anuh Pharma's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Anuh Pharma ranks #584 out of 960 companies for FCF Margin %. This places Anuh Pharma in the lower half of its industry. The industry median FCF Margin % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Anuh Pharma and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anuh Pharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anuh Pharma stock overvalued right now?
Based on GuruFocus' analysis, Anuh Pharma (BOM:506260) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹105.32, compared to a current price of ₹81.49 — trading 22.6% below its estimated fair value. The current FCF Margin % is 0.00%. Anuh Pharma's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Anuh Pharma (BOM:506260), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anuh Pharma (BOM:506260) Overvalued in 2026?
Based on GuruFocus' analysis, Anuh Pharma stock appears to be undervalued.
The current stock price of ₹81.49 is trading 22.6% below its estimated GF Value™ of ₹105.32.
GuruFocus considers Anuh Pharma to be Modestly Undervalued.
Key valuation signals for BOM:506260:
FCF Margin %: 0.00%
GF Value™: ₹105.32 vs. price of ₹81.49 (22.6% below fair value)
No single metric tells the full story. See the BOM:506260 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.
81GF Score
Get the complete analysis for BOM:506260
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506260 has been successfully added to your 
